E-cadherin expression in upper-urinary-tract carcinoma

International Journal of Cancer

Volumn 74, Issue 4, 1997, Pages 446-449

  Nakanishi, Kuniaki ^a   Kawai, Toshiaki ^a   Torikata, Chikao ^a   Aurues, Takashi ^a   Ikeda, Tomosumi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CADHERINS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0030799876     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970822)74:4<446::AID-IJC15>3.0.CO;2-7     Document Type: Article

References (25)

1. AKAZA, H., KOISO, K. and NIIJIMA. T., Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system. Cancer; 59, 1360-1375 (1987).
2. BATATA, M. and GRABSTALD, H., Upper-urinary-tract urothelial tumors. Urol. Clin. North Amer., 3, 79-86 (1976).
3. BRINGUIER, P.P., UMBAS, R., SCHAAFSMA, H.E., KARTHAUS, H.F.M., DEBRUYNE, F.M.J. and SCHALKEN, J.A., Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res., 53, 3241-3245 (1993).
4. DAS, A.K., CARSON, C.C., BOLICK, D. and PAULSON, D.F., Primary carcinoma of the upper urinary tract: effect of primary and secondary therapy on survival. Cancer, 66, 1919-1923 (1990).
5. DORUDI, S., SHEFFIELD, J.P., POULSOM, R., NORTHOVER, J.M.A. and HART, I.R., E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Amer. J. Pathol., 142, 981-986 (1993).
6. GAMALLO, C., PALACIOS, J., SUAREZ, A., PIZARRO, A., NAVARRO, P., QUINTANILLA, M. and CANO, A., Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Amer. J. Pathol., 142, 987-993 (1993).
7. HUBEN, R.P., MOUNZER, A.M. and MURPHY, G.P., Tumor grade and stage as prognostic variables in upper-tract urothelial tumors. Cancer, 62, 2016-3020 (1988).
8. KINSELLA, A.R., GREEN, B., LEPTS, G.C., HILL, C.L., BOWIE, G. and TAYLOR, B.A., The role of the cell-cell adhesion molecule E-cadherin in large-bowel-tumour-cell invasion and metastasis. Brit. J. Cancer, 67, 904-909 (1993).
9. LIPPONEN, P.K. and ESKELINEN, M.J., Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J. Cancer Res. clin. Oncol., 121, 303-308 (1995).
10. LIPPONEN, P., SAARELAINEN, E., JI, H., AALTOMAA, S. and SYRJÄNEN, K., Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J. Pathol., 174, 101-109 (1994).
11. MOLL, R., MITZE, M., FRIXEN, U.H. and BIRCHMEIER, W., Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Amer. J. Pathol., 143, 1731-1742 (1993).
12. MURPHY, D.M., ZINCKE, H. and FURLOW, W.L., Management of high-grade transitional-cell cancer of the upper urinary tract. J. Urol., 125, 25-29 (1981).
13. MURPHY, W.M., BECKWITH, J.B. and FARROW, G.M., Tumors of the kidney, bladder, and related urinary structures, Atlas of tumor pathology, third series, fasc. 11, pp. 202-219. Armed Forces Institute of Pathology, Washington, DC (1994).
14. OKA, H., SHIOZAKI, H., KOBAYASHI, K., TAHARA, H., TAMURA, S., MIYATA, M., DOKI, Y., IIHARA, K., MATSUYOSHI, N., HIRANO, S., TAKEICHI, M. and MORI, T., Immunohistochemical evaluation of E-cadherin-adhesion-molecule expression in human gastric cancer. Virchows Archiv (A), Pathol. Anat., 421, 149-156 (1992).
15. OTTO, T., BIRCHMEIER, W., SCHMIDT, U., HINKE, A., SCHIPPER, J., RÜBBEN, H. and RAZ, A., Inverse relation of E-cadherin and autocrine-motility-factor-receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res., 54, 3120-3123 (1994).
16. PIGNATELLI, M., E-cadherin: a biological marker of tumour differentiation. J. Pathol., 171, 81-82 (1993).
17. ROSS, J.S., DEL ROSARIO, A.D., FIGGE, H.L., SHEEHAN, C., FISHER, H.A.G. and BUI, H.X., E-cadherin expression in papillary transitional-cell carcinoma of the urinary bladder. Hum. Pathol., 26, 940-944 (1995).
18. SAS, SAS/STAT SOFTWARE: THE PHREG PROCEDURE, VERSION 6, SAS TECHNICAL REPORT P-217, P. 63. SAS INSTITUTE INC., CARY, NC (1991).
19. SHINO, Y., WATANABE, A., YAMADA, Y., TANASE, M., YAMADA, T., MATSUDA, M., YAMASHITA, J., TATSUMI, T., MIWA, T. and NAKANO, H., Clinicopathologic evaluation of immunohistochemical-E-cadherin expression in human gastric carcinomas. Cancer, 76, 2193-2201 (1995).
20. SYRIGOS, K.N., KRAUSZ, T., WAXMAN, J., PANDHA, H., ROWLINSON-BUSZA, G., VERNE, J., EPENETOS, A.A. and PIGNATELLI, M., E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int. J. Cancer (Predict. Oncol.), 64, 367-370 (1995).
21. TAKEICHI, M., Cadherins: a molecular family important in selective cell-cell adhesion. Ann. Rev. Biochem., 59, 237-252 (1990).
22. TAKEICHI, M., Cadherin-cell-adhesion receptors as a morphogenetic regulator. Science, 251, 1451-1455 (1991).
23. UICC (INTERNATIONAL UNION AGAINST CANCER), Renal pelvis and ureter. In: Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours, 3rd ed., 2nd revision, pp. 270-273, Springer, Berlin (1992).
24. UMBAS, R., ISAACS, W.B., BRINGUIER, P.P., SCHAAFSMA, H.E., KARTHAUS, H.F.M., OOSTERHOF, G.O.N., DEBRUYNE, F.M.J. and SCHALKEN, J.A., Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54, 3929-3933 (1944).
25. VLEMINCKX, K., VAKAET, L., MAREEL, M., FIERS, W. and VAN ROY, F., Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals un invasion-suppressor role. Cell, 66, 107-119 (1991).